Tag Archives: SickleCell

Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?

The Food and Drug Administration recently approved two transformative new treatments for sickle-cell disease, the first in 20 years. But the drugs are wildly expensive, renewing troubling questions about access to cutting-edge medicines. Adakveo, made by Novartis, can prevent episodes of nearly unbearable pain that occur when malformed blood cells get stuck in blood vessels.… Read More »